In lieu of an abstract, here is a brief excerpt of the content:

275 AARP. See American Association of Retired Persons accidents, 84, 95; and fractures, 64 Adams, Brock, 190 Adams, John, 7–8 adrenaline, 27 Aegerter, Ernest, 47 African Americans, 40, 127 age categories, development of, 11–13 aged: alleviation of disabilities of, 56; attitudes toward, 1–2, 6–23; decline in respect for, 8–22; definition of, 6; increase in number of, 50–51, 55; and obsolescence, 14; as political force, 125–26; proportion of, in population, 6–7, 19–20; rejection of concept of decline of, 55–56; respect for, in colonial America, 7 ageism, 55 Agency for Healthcare Research and Quality, 179, 188, 194–95 aging: and bone loss, 60; dangers of, 83; vs disease, 43–45; female, medicalization of, 30–31; and sex hormones, 66 AHRQ. See Agency for Healthcare Research and Quality Aitkin, John M., 144 Albright, Fuller, 33, 41, 48, 58, 174, 176, 227, 229; career of, 34–39; and parathyroid hormone, 31; and postmenopausal osteoporosis, 34–39; scientific contributions of, 35–37 Albright’s Syndrome, 35 alcoholism, 95 alendronate, 156–64, 184, 194, 200; and femur fractures, 216–17; and fracture risk, 197; outcome data for, 196 Allen, Edgar, 29–30, 66 Aloia, John F., 96 Alonso-Coello, Pablo, 226 American Academy of Physical Medicine and Rehabilitation, 166 American Association of Retired Persons, 112, 116, 125 American Cancer Society, 150 American College of Nuclear Physicians, 104 American College of Obstetricians and Gynecologists, 166, 209 American College of Physicians; and estrogen guidelines, 148–49; and guidelines for drug treatment, 197; and pharmacologic treatment for osteoporosis, 211; and report on BMD, 103 American College of Preventive Medicine, 207 American Council on Science and Health, 77 American Geriatrics Society, 166 American Society for Bone and Mineral Research , 166, 204; and American Home Products Corporation, 163–64; on bisphosphonate-associated osteonecrosis , 216–17; and fall prevention, 213–14 Amgen, 221 Anderson, D. C., 158 Angell, Marcia, 227 Aristotle, 2 Association for the Study of Internal Secretions , 28 Aub, Joseph C., 34 Avioli, Louis V., 83, 112, 113, 116, 117 Ayerst Laboratories, 75–76, 81, 90, 110, 147; and Premarin, 70 Baldwin, F. Spencer, 19 Banting, Frederick, 29 INDEX 276 Index Barzel, Urial S., 63–64 Battey’s operation, 28 Bauer, Göran C. H., 44 Bayesian analysis of RCTs of bisphosphonate , 196 Bayliss, William M., 27 Beard, George M., 15 Beeson, Paul B., 228 Bernard, Claude, 26 Best, Charles H., 29 Bible, 2 Bichet, Xavier, 13 Bigelow, George H., 21 biomedicalizaton of aging, 225–26 Bisphosphonates in Bone Disease (Fleisch), 154 bisphosphonate therapy, 115–16, 124, 153–64, 180, 194, 197–99, 223; and safety, 215–19 BMD. See bone mineral density Boas, Ernst, 21 Bone (McLean and Urist), 46–47 bone: aging, 50; atrophy of, 25, 31; changes in, 3; history of, 2–6; loss of, 97; physiology of, ignored, 46; quality and fragility of, 126; remodeling of, 4, 24–25; resorption of, 1, 22–24, 36, 46, 48, 50, 111; and role of technology, 3–4 Bone and Joint Decade (2002–2011), 177 Bone Health and Osteoporosis (2004), 189–90, 193–94 Bone Measurement Institute, 163 bone mineral density (BMD), 58, 103–6, 108, 127, 132, 175, 180, 202; and bisphosphonates, 103–6, 108, 127, 160, 180; and fracture, 126–27, 133–35, 140–42, 195; measurements of, 95; and physical activity, 123; physiological theories, 42–44; and screening, 202; and T-score, 131 bone multicellular unit (BMU), 48 bone research; concentrated in U.S., 120–21; impact of WWI and WWII on, 39–40; and weakness in knowledge base, 39–47, 117–18, 127–28 Break Study, 145 Breast Cancer Detection Demonstration Project, 183 British Columbia Office of Technology Assessment, 170–77 British Menopause Society, 219 Brown-Séquard, Charles-Édouard, 14, 26 Bush, George H. W., 177 Butler, Robert N., 55 Cabanela, Miguel E., 65 Calcified Tissue International, 40, 122 Calcified Tissue Research, 40 calcioprotective law, 34 calcitonin, 63, 107, 111–12, 114, 122, 124, 147–48, 167, 194, 196 calcium, 18, 33, 38, 50, 63, 94, 96, 107, 112, 124, 127, 129, 145–47, 161, 166–67, 180, 193, 222; deficiency of, 41, 88–90, 192; lack of studies of efficacy of, 113; metabolism of, 31, 34, 37; therapy with, 122 Calix, Karim A., 199 Canada, 220–21 cancer: breast, 37, 62, 74–75, 79, 111, 124, 148–51, 164, 183, 185–86; and breast surgery , 90–91; cervical, 37; colorectal, 150, 183, 187; endometrial, 37, 62...

Share